These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

244 related items for PubMed ID: 16528475

  • 1. Regulation of survivin by retinoic acid and its role in paclitaxel-mediated cytotoxicity in MCF-7 breast cancer cells.
    Pratt MA, Niu MY, Renart LI.
    Apoptosis; 2006 Apr; 11(4):589-605. PubMed ID: 16528475
    [Abstract] [Full Text] [Related]

  • 2. Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells.
    Niu MY, Ménard M, Reed JC, Krajewski S, Pratt MA.
    Oncogene; 2001 Jun 14; 20(27):3506-18. PubMed ID: 11429697
    [Abstract] [Full Text] [Related]

  • 3. Prodigiosin down-regulates survivin to facilitate paclitaxel sensitization in human breast carcinoma cell lines.
    Ho TF, Peng YT, Chuang SM, Lin SC, Feng BL, Lu CH, Yu WJ, Chang JS, Chang CC.
    Toxicol Appl Pharmacol; 2009 Mar 01; 235(2):253-60. PubMed ID: 19133282
    [Abstract] [Full Text] [Related]

  • 4. Adenovirus-mediated inhibition of survivin expression sensitizes human prostate cancer cells to paclitaxel in vitro and in vivo.
    Zhang M, Mukherjee N, Bermudez RS, Latham DE, Delaney MA, Zietman AL, Shipley WU, Chakravarti A.
    Prostate; 2005 Aug 01; 64(3):293-302. PubMed ID: 15754318
    [Abstract] [Full Text] [Related]

  • 5. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
    Fujie Y, Yamamoto H, Ngan CY, Takagi A, Hayashi T, Suzuki R, Ezumi K, Takemasa I, Ikeda M, Sekimoto M, Matsuura N, Monden M.
    Jpn J Clin Oncol; 2005 Aug 01; 35(8):453-63. PubMed ID: 16024531
    [Abstract] [Full Text] [Related]

  • 6. Involvement of p21 in mitotic exit after paclitaxel treatment in MCF-7 breast adenocarcinoma cell line.
    Barboule N, Chadebech P, Baldin V, Vidal S, Valette A.
    Oncogene; 1997 Dec 04; 15(23):2867-75. PubMed ID: 9419978
    [Abstract] [Full Text] [Related]

  • 7. [Asiaticoside inducing apoptosis of tumor cells and enhancing anti-tumor activity of vincristine].
    Huang YH, Zhang SH, Zhen RX, Xu XD, Zhen YS.
    Ai Zheng; 2004 Dec 04; 23(12):1599-604. PubMed ID: 15601545
    [Abstract] [Full Text] [Related]

  • 8. Tumor-specific RNAi targeting eIF4E suppresses tumor growth, induces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells.
    Dong K, Wang R, Wang X, Lin F, Shen JJ, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Feb 04; 113(3):443-56. PubMed ID: 18327707
    [Abstract] [Full Text] [Related]

  • 9. Sequential dependent enhancement of caspase activation and apoptosis by flavopiridol on paclitaxel-treated human gastric and breast cancer cells.
    Motwani M, Delohery TM, Schwartz GK.
    Clin Cancer Res; 1999 Jul 04; 5(7):1876-83. PubMed ID: 10430095
    [Abstract] [Full Text] [Related]

  • 10. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells.
    Chou CC, Yang JS, Lu HF, Ip SW, Lo C, Wu CC, Lin JP, Tang NY, Chung JG, Chou MJ, Teng YH, Chen DR.
    Arch Pharm Res; 2010 Aug 04; 33(8):1181-91. PubMed ID: 20803121
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Suppression of survivin phosphorylation on Thr34 by flavopiridol enhances tumor cell apoptosis.
    Wall NR, O'Connor DS, Plescia J, Pommier Y, Altieri DC.
    Cancer Res; 2003 Jan 01; 63(1):230-5. PubMed ID: 12517802
    [Abstract] [Full Text] [Related]

  • 13. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q, Yang W, Uytingco MS, Christakos S, Wieder R.
    Cancer Res; 2000 Apr 01; 60(7):2040-8. PubMed ID: 10766196
    [Abstract] [Full Text] [Related]

  • 14. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 01; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 15. Survivin deregulation in beta-tubulin mutant ovarian cancer cells underlies their compromised mitotic response to taxol.
    Zhou J, O'brate A, Zelnak A, Giannakakou P.
    Cancer Res; 2004 Dec 01; 64(23):8708-14. PubMed ID: 15574781
    [Abstract] [Full Text] [Related]

  • 16. Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.
    Galmarini CM, Falette N, Tabone E, Levrat C, Britten R, Voorzanger-Rousselot N, Roesch-Gateau O, Vanier-Viornery A, Puisieux A, Dumontet C.
    Br J Cancer; 2001 Sep 14; 85(6):902-8. PubMed ID: 11556844
    [Abstract] [Full Text] [Related]

  • 17. Overexpression of Survivin and XIAP in MDR cancer cells unrelated to P-glycoprotein.
    Shi Z, Liang YJ, Chen ZS, Wang XH, Ding Y, Chen LM, Fu LW.
    Oncol Rep; 2007 Apr 14; 17(4):969-76. PubMed ID: 17342344
    [Abstract] [Full Text] [Related]

  • 18. Survivin plays as a resistant factor against tamoxifen-induced apoptosis in human breast cancer cells.
    Moriai R, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2009 Sep 14; 117(2):261-71. PubMed ID: 18815881
    [Abstract] [Full Text] [Related]

  • 19. Tumor-specific adenovirus-mediated PUMA gene transfer using the survivin promoter enhances radiosensitivity of breast cancer cells in vitro and in vivo.
    Wang R, Wang X, Li B, Lin F, Dong K, Gao P, Zhang HZ.
    Breast Cancer Res Treat; 2009 Sep 14; 117(1):45-54. PubMed ID: 18791823
    [Abstract] [Full Text] [Related]

  • 20. 15-deoxy-Delta(12,14)-prostaglandin J2 inhibits G2-M phase progression in human breast cancer cells via the down-regulation of cyclin B1 and survivin expression.
    Kamagata C, Tsuji N, Moriai M, Kobayashi D, Watanabe N.
    Breast Cancer Res Treat; 2007 May 14; 102(3):263-73. PubMed ID: 17028981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.